In a report released today, Crispin Love from Piper Sandler maintained a Hold rating on Enfusion (ENFN – Research Report), with a price target of $10.00. The company’s shares closed yesterday at $9.66.
Love covers the Real Estate sector, focusing on stocks such as AGNC Investment, Annaly Capital, and Ellington Financial. According to TipRanks, Love has an average return of 10.2% and a 70.00% success rate on recommended stocks.
Currently, the analyst consensus on Enfusion is a Hold with an average price target of $10.20.
The company has a one-year high of $11.56 and a one-year low of $7.37. Currently, Enfusion has an average volume of 418.3K.
Based on the recent corporate insider activity of 84 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ENFN in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Enfusion (ENFN) Company Description:
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute better-informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth.
Read More on ENFN:
